Primary Cells

Human Acute Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated)

  • For research use only

Cat No.

ABC-TC3011

Product Type

Blood Products

Cell Type

Plasma

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Lymphoid Leukemia

Storage

Liquid Nitrogen

Human Acute Lymphoid Leukemia PB Plasma supports leukemia biomarker analysis, diagnostic assay development, and hematologic disease research.

Product Image

Description

Human Acute Lymphoid Leukemia Peripheral Blood Plasma (Newly Diagnosed/Untreated) is an acellular plasma fraction isolated from peripheral blood of adult patients newly diagnosed with acute lymphoid leukemia (ALL), predominantly B-ALL with occasional T-ALL cases. This clear, cell-free plasma contains leukemia-associated soluble immune mediators and circulating extracellular vesicles, reflecting the systemic leukemic microenvironment and supporting studies of novel biomarkers in untreated ALL plasma and plasma signatures in leukemia diagnosis. To ensure the quality of these primary cells, repeated freeze-thaw cycles are not recommended due to the fragile nature of these cells. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Acute Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated), ALL PB plasma ND/UT, Human ALL PB plasma

Species

Human

Cat.No

ABC-TC3011

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Plasma

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Lymphoid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Blood Products

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • This peripheral blood plasma is ideal for use in leukemia-related biomarker discovery, cfDNA/cfRNA analysis, cytokine quantification, and extracellular vesicle research. It serves as a valuable sample for the development of liquid biopsy-based diagnostics, evaluation of systemic immune modulation, and exploration of early-stage leukemic signatures. Compatible with high-throughput technologies such as qPCR, ELISA, NGS, and proteomics, it supports both translational and mechanistic studies into the molecular landscape of newly diagnosed ALL.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Acute Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button